S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Clinical trial NCT00053833 · TERMINATED
Trial details
- NCT number
- NCT00053833
- Sponsor
- SWOG Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2004-07-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.